Who Owns Citius Oncology, Inc. (CTOR)?Hedge Fund & Institutional Holders

$0.80-0.11 (-12.08%)HealthcareNASDAQ

Institutional Holders

23

as of Q4 2025

Total Institutional Value

$5.584475121210999e+21T

% of Float Held

1.174548192504312e+99%

QoQ Change in Holders

+7 / -4

Price History

$0.57$1.75$2.93$4.11$5.29Aug 24Jun 25Mar 26

CTOR — Biggest New Institutional Buyers This Quarter

FundActionShares AddedValue Added
Versant Capital Management, IncNew Position+2K+$1K
ROYAL BANK OF CANADANew Position+23+$0
OMERS ADMINISTRATION CorpNew Position+105K+$0
TWO SIGMA INVESTMENTS, LPNew Position+24K+$0
TWO SIGMA SECURITIES, LLCNew Position+13K+$0
Arkadios Wealth AdvisorsNew Position+12K+$0
BlackRock, Inc.New Position+22K+$0
UBS Group AGIncreased+21K+$-91K
NORTHERN TRUST CORPIncreased+24K+$-44.2M
IFP Advisors, IncIncreased+54K+$-67.4M
GEODE CAPITAL MANAGEMENT, LLCIncreased+53K+$-339.4M
VANGUARD GROUP INCIncreased+417K+$-365.1M

CTOR — Institutions Reducing or Closing Positions

FundActionShares SoldValue Sold
ARMISTICE CAPITAL, LLCDecreased-2.1M-$15.6B
XTX Topco LtdDecreased-53K-$257.6M
RENAISSANCE TECHNOLOGIES LLCClosed Position-56K-$113.5M
CITADEL ADVISORS LLCClosed Position-18K-$35.9M
OSAIC HOLDINGS, INC.Decreased-320-$25.2M
Tower Research Capital LLC (TRC)Closed Position-12K-$24.0M
BANK OF AMERICA CORP /DE/Decreased-50-$536K
MORGAN STANLEYClosed Position-5-$10K

Top Institutional Holders(Q4 2025)

#FundSharesValue% of PortfolioType
1ARMISTICE CAPITAL, LLC5,584,080$5.6M0.07%Share
2VANGUARD GROUP INC475,087$475K0.00%Share
3VANGUARD GROUP INC121,910$121K0.00%Share
4UBS Group AG21,453$21K0.00%Share
5Versant Capital Management, Inc1,500$1K0.00%Share
6OSAIC HOLDINGS, INC.11,425$00.00%Share
7XTX Topco Ltd73,992$00.00%Share
8STATE STREET CORP42,900$00.00%Share
9IFP Advisors, Inc87,424$00.00%Share
10GEODE CAPITAL MANAGEMENT, LLC178,566$00.00%Share
11GEODE CAPITAL MANAGEMENT, LLC41,481$00.00%Share
12ROYAL BANK OF CANADA23$00.00%Share
13UBS Group AG11$00.00%Share
14TWO SIGMA SECURITIES, LLC13,360$00.00%Share
15BANK OF AMERICA CORP /DE/44$00.00%Share
16BANK OF AMERICA CORP /DE/170$00.00%Share
17NORTHERN TRUST CORP45,746$00.00%Share
18OMERS ADMINISTRATION Corp104,500$00.00%Share
19Arkadios Wealth Advisors11,666$00.00%Share
20BlackRock, Inc.2,491$00.00%Share
21BlackRock, Inc.19,853$00.00%Share
22TWO SIGMA INVESTMENTS, LP23,515$00.00%Share
23Farther Finance Advisors, LLC3$00.00%Share

CTOR Institutional Ownership History

QuarterHoldersTotal ValueChange
Q4 202518$6.2M+3
Q3 202515$16.9B+8
Q2 20257$966.3M+0
Q1 20257$108.8M-5
Q4 202412$163.7M+7
Q3 20245$2.5B—

Similar Stocks by Institutional Ownership

LLY

Eli Lilly and Company

JNJ

Johnson & Johnson

ABBV

AbbVie Inc.

NVS

Novartis AG

AZN

AstraZeneca PLC

MRK

Merck & Co., Inc.

UNH

UnitedHealth Group Incorporated

AMGN

Amgen Inc.

As of Q4 2025, 23 institutional investors hold CTOR (Citius Oncology, Inc.). The largest holder is ARMISTICE CAPITAL, LLC with $5.6M in shares. This quarter, 7 institutions opened new positions and 4 closed their positions.

Frequently Asked Questions

How many hedge funds own CTOR?

As of Q4 2025, 23 institutional investors report holding CTOR (Citius Oncology, Inc.) in their 13F filings.

Who is the largest institutional holder of CTOR?

The largest institutional holder of CTOR is ARMISTICE CAPITAL, LLC with $5.6M in shares.

Is institutional ownership of CTOR increasing or decreasing?

This quarter, 7 institutions opened new positions in CTOR and 4 closed their positions.